Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CANCER: Developing Molecular Biomarkers for Cancer
David F. Ransohoff
For decades, biologists have sought to develop noninvasive tests for detecting cancer. In a Perspective, Ransohoff discusses new work that could be applied to developing a noninvasive test for detecting colorectal cancer (Cui et al.).
The author is in the Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7080, USA, and at the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. E-mail: ransohof{at}med.unc.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Hengmi Cui, Marcia Cruz-Correa, Francis M. Giardiello, David F. Hutcheon, David R. Kafonek, Sheri Brandenburg, Yiqian Wu, Xiaobing He, Neil R. Powe, and Andrew P. Feinberg (14 March 2003) Science299 (5613), 1753.
[DOI: 10.1126/science.1080902] |Abstract »|Full Text »|PDF »|Supporting Online Material »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Clinical Utility of Tumor Markers: Study Design and Evaluation.
D. F. Hayes (2009)
Am. Assoc. Cancer Res. Educ. Book
2009, 273-277
|Full Text »|PDF »
Research Issues Affecting Preoperative Systemic Therapy for Operable Breast Cancer.
A. C. Wolff, D. Berry, L. A. Carey, M. Colleoni, M. Dowsett, M. Ellis, J. E. Garber, D. Mankoff, S. Paik, L. Pusztai, et al. (2008)
J. Clin. Oncol.
26, 806-813
|Abstract »|Full Text »|PDF »
Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics.
